Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan

被引：0
|
作者：
Taku Aoki
Norihiro Kokudo
Izumi Komoto
Kyoichi Takaori
Wataru Kimura
Keiji Sano
Takeshi Takamoto
Takuya Hashimoto
Takuji Okusaka
Chigusa Morizane
Tetsuhide Ito
Masayuki Imamura
机构：
[1] The University of Tokyo,Hepato
[2] The University of Tokyo,Biliary
[3] Kansai Electric Power Company Hospital,Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine
[4] Kyoto University,Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine
[5] Yamagata University Faculty of Medicine,Department of Surgery
[6] Teikyo University School of Medicine,Department of Hepatobiliary
[7] Japanese Red Cross Medical Center,Pancreatic Surgery and Transplantation, Graduate School of Medicine
[8] National Cancer Center Hospital,Department of Gastroenterological, Breast, Thyroid, and General Surgery
[9] Kyushu University,Department of Surgery
来源：
Journal of Gastroenterology | 2015年 / 50卷
关键词：
Neuroendocrine tumors; Streptozocin; Multi-center survey; Tumor response; Progression-free survival rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：769 / 775
页数：6
相关论文
共 50 条
  • [41] Outcomes of Cytoreductive Surgery for Well-Differentiated Metastatic Neuroendocrine Tumors in the Setting of Extrahepatic Metastases
    Hallet, J.
    Koudjanian, S.
    Beyfuss, K.
    Coburn, N.
    Karanicolas, P.
    Singh, S.
    Law, C.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S96 - S97
  • [42] Report of 177Lu-DOTATATE Therapy in Patients with Well-differentiated Metastatic Neuroendocrine Tumors: A Single Center Experience
    Abiodun-Ojo, Olayinka
    Shaib, Walid
    Fourzali, Yamil
    Rupji, Manali
    Switchenko, Jeffrey
    Muzahir, Saima
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [43] Defining prognostic parameters of well-differentiated gastric neuroendocrine tumors based on metastatic potential: a two-center experience
    Kurtulan, O.
    Turhan, N.
    Gedikoglu, G.
    Akyol, A.
    Sokmensuer, C.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2022, 85 (02) : 339 - 345
  • [44] The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors.
    Raymond, Eric
    Kulke, Matthew H.
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina E.
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul Eliezer
    Ito, Tetsuhide
    Fernandez, Kathrine C.
    Rosbrook, Brad
    Fazio, Nicola
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [45] Angiogenic profiling in patients with advanced well-differentiated pancreatic neuroendocrine tumors treated with everolimus
    Cella, C. A.
    Spada, F.
    Galdy, S.
    Frezza, A. M.
    Catapano, M.
    Funicelli, L.
    Calleri, A.
    Zorzino, L.
    Mancuso, P.
    Radice, D.
    Fazio, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S449 - S449
  • [46] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Hai-Yan Chen
    Yao Pan
    Jie-Yu Chen
    Lu-lu Liu
    Yong-Bo Yang
    Kai Li
    Ri-Sheng Yu
    Guo-Liang Shao
    European Radiology, 2022, 32 : 8317 - 8325
  • [47] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Chen, Hai-Yan
    Pan, Yao
    Chen, Jie-Yu
    Liu, Lu-lu
    Yang, Yong-Bo
    Li, Kai
    Yu, Ri-Sheng
    Shao, Guo-Liang
    EUROPEAN RADIOLOGY, 2022, 32 (12) : 8317 - 8325
  • [48] Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis
    Junho Kang
    Changhoon Yoo
    Hee-Sang Hwang
    Seung-Mo Hong
    Kyu-pyo Kim
    Sun Young Kim
    Yong-Sang Hong
    Tae Won Kim
    Baek-Yeol Ryoo
    Investigational New Drugs, 2019, 37 : 763 - 770
  • [49] Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis
    Kang, Junho
    Yoo, Changhoon
    Hwang, Hee-Sang
    Hong, Seung-Mo
    Kim, Kyu-pyo
    Kim, Sun Young
    Hong, Yong-Sang
    Kim, Tae Won
    Ryoo, Baek-Yeol
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (04) : 763 - 770
  • [50] CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience
    Sahu, Arvind
    Jefford, Michael
    Lai-Kwon, Julia
    Thai, Alesha
    Hicks, Rodney J.
    Michael, Michael
    JOURNAL OF ONCOLOGY, 2019, 2019
12345